HIV-associated Hodgkin's Lymphoma. Antiapoptotic Pathways and Mechanisms for Immune Escape by Tumor Cells in the Setting of Improved Immunity

Schwering I. , Bräuninger A. , Klein U. . Loss of the B-lineage-specific gene expression program in Hodgkin's and Reed-Sternberg cells of Hodgkin's lymphoma. Blood 2003; 101: 1505–12.

Kanzler H. , Küppers R. , Hansmann M.L. , Rajewsky K. . Hodgkin's and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 1996; 184: 1495–505.

Bräuninger A. , Schmitz R. , Bechtel D. , Renne C. , Hansmann M.L. , Küppers R. . Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma. Int J Cancer 2006; 118: 1853–61.

Re D. , Küppers R. , Diehl V. . Molecular pathogenesis of Hodgkin's lymphoma. J Clin Oncol 2005; 23: 6379–86.

Carbone A. , Gloghini A. , Gattei V. . Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood 1995; 85: 780–9.

Carbone A. , Gloghini A. , Gruss H-J , Pinto A. . CD40 ligand is constitutively expressed in a subset of T-cell lymphomas and on the microenvironmental reactive T-cells of follicular lymphomas and Hodgkin's disease. Am J Pathol 1995; 147: 912–22.

Gires O. , Zimber-Strobl U. , Gonnella R. . Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J 1997; 16: 6131–40.

Takahashi T. , Tagami T. , Yamazaki S. . Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192: 303–10.

Piccirillo C.A. , Shevach E.M. . Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells? J Immunol 2001; 167: 1137–40.

Apoil P.A. , Puissant B. , Roubinet F. , Abbal M. , Massip P. , Blancher A. . FOXP3 mRNA levels are decreased in peripheral blood CD4+ lymphocytes from HIV-positive patients. J Acquir Immune Defic Syndr 2005; 39: 381–5.

Alvaro T. , Lejeune M. , Salvado M.T. . Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 2005; 11: 1467–73.

Carbone A. , Gloghini A. , Larocca L.M. . HIV-associated Hodgkin's disease derives from post-germinal center B-cells. Blood 1999; 93: 2319–26.

Herida A. , Mary-Krause M. , Kaphan R. . Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003; 21: 3447–53.

Clifford G.M. , Polesel J. , Rickenbach M. . Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005; 97: 425–32.

Engels E.A. , Pfeiffer R.M. , Goedert J.J. . Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS 2006; 20: 1645–54.